Deep Research for Pre-Seed Pitch Deck | April 2026
Preventable home emergencies cost the US healthcare system $88B+ per year. This figure represents the total economic burden across three major threat categories affecting seniors living at home.
| Threat | Annual Cost | Deaths/yr | Key Stat | Source |
|---|---|---|---|---|
| Falls | $50B (conservative; updated CDC data shows ~$80B) | 41,400 | 14M seniors fall annually; 50% can't get up alone; 3M+ ER visits | CDC NCHS Data Brief 2023, Florence et al. 2018 |
| Delayed Discovery | $30B+ (worsened outcomes from late response) | Included in falls/other | ~500K long-lie incidents/yr; mortality jumps dramatically with discovery time | BMC Geriatrics 2023 Scoping Review |
| Home Fires | $8.4B property damage (~$8.9B avg 2019-2023) | 3,500 | Seniors have 2-4x fire death rate; 85+ have 3.2x overall rate | NFPA Home Structure Fires |
Primary source: Florence CS, Bergen G, Atherly A, et al. "Medical Costs of Fatal and Nonfatal Falls in Older Adults." Journal of the American Geriatrics Society (JAGS), 2018.
Data year: 2015
Methodology: Quasi-experimental regression analysis comparing total healthcare spending of older adults who experienced falls against a matched control group who did not fall, isolating the incremental cost attributable to falls.
Data sources used:
Cost breakdown by payer:
| Payer | Amount | Share |
|---|---|---|
| Medicare | $28.9B | 58% |
| Medicaid | $8.7B | 17% |
| Private + other payers | $12.0B | 24% |
| Fatal falls (all payers) | $0.754B | 1% |
| Total | ~$50.0B | 100% |
What IS included:
What is NOT included (making $50B conservative):
A 2024 CDC study recalculated using 2020 data and found non-fatal falls alone now cost approximately $80B/year:
| Component | Amount |
|---|---|
| Medicare + Medicaid | $57B |
| Private + other payers | $23B |
| Total (non-fatal only) | ~$80B |
Acute care breakdown: 922,428 inpatient visits + 2.3M ED visits = $19.8B in acute care costs alone
Why the jump from $50B → $80B in 5 years:
The $50B on the slide is the peer-reviewed, CDC-backed, conservative figure. In investor conversations, the follow-up is:
"We use $50B because it's the most-cited peer-reviewed number. But the CDC's own 2024 update puts non-fatal falls alone at $80B. Add delayed discovery costs and home fires, and the real number is likely $120B+. Our $88B headline is deliberately conservative."
Investor takeaway: The $88B figure is likely conservative. Using updated CDC data, falls alone cost ~$80B, making the real total closer to $120B+.
While the problem costs $88B+, current spending on prevention technology is only ~$2B in the US. This 44:1 ratio between damage and prevention is the core market opportunity.
| Category | US Market Size (2024) | CAGR | Projected Size |
|---|---|---|---|
| PERS / Medical Alert Systems | ~$1.7-2.4B | 5.1-6.4% | $2.2B (2029) |
| Remote Patient Monitoring | ~$14.2B | 12.8% | $29.1B (2030) |
| Aging-in-Place Technology | ~$9.1B | 15.1% | $15.2B (2033) |
| Smart Home Healthcare | $5.9B (global) | 8.95% | — |
| Spending Type | Annual Amount | Category |
|---|---|---|
| Medicare/Medicaid on fall-related treatment | $57B | Reactive (after the fall) |
| Private payer fall treatment | $23B | Reactive (after the fall) |
| Total reactive spending | $80B | Treating consequences |
| PERS devices (prevention tech) | ~$2B | Proactive (before the fall) |
| Prevention-to-treatment ratio | 1:40 | Massive underinvestment |
Investor takeaway: The healthcare system spends $80B treating falls but only ~$2B trying to prevent them. Every $1 invested in prevention technology that reduces falls by even 10% would save $8 in treatment costs.
| Year | Population 65+ | % of Total | Milestone |
|---|---|---|---|
| 2020 | 55.8M | 16.8% | Fastest decade of growth since 1880-1890 |
| 2024 | 61.2M | 18.2% | Current |
| 2025 | ~62.7M | 18.6% | — |
| 2030 | 71.6M | 20.7% | 1 in 5 Americans will be 65+; all Baby Boomers over 65 |
| 2035 | 78.0M | 22.1% | Older adults outnumber children for first time in US history |
10-year growth (2024→2035): +28% — adding 16.8M people to the 65+ cohort.
| Age Group | Growth Rate | Why It Matters |
|---|---|---|
| 65-74 | ~2.5% CAGR | Largest segment, beginning to need monitoring |
| 75-84 | ~3% annually | Primary buyer segment — families seeking solutions |
| 85+ | ~5% annually through 2030 | Highest fall risk, highest fire death rate, most likely to live alone |
| Stat | Value | Source |
|---|---|---|
| Seniors living alone | 16.2M (28% of 65+ population) | ACL Profile 2023 |
| Have no alert system | ~90% | TheSeniorList 2023 |
| Pendant non-activation | 80% | Fleming & Brayne BMJ 2008 / JMIR 2021 |
| Want to age in place | 75% of adults 50+ | AARP 2024 |
| Americans turning 65 daily | ~10,000 | Ongoing since 2011 |
| Market | Size | Timeframe | Growth |
|---|---|---|---|
| US Home Healthcare | $162B | 2024 | 9.8% CAGR → $284B by 2030 |
| Global Elderly Monitoring | $9.52B | 2034 projection | From $3.84B (2025) |
| Global Ambient Assisted Living | $132B | 2024 | 30.8% CAGR |
| US Gerontechnology | $69.6B | 2024 | 13.0% CAGR → $245.6B by 2033 |
| Segment | US Market | CAGR | Why Relevant |
|---|---|---|---|
| PERS / Medical Alerts | $2B | 5-6% | Direct replacement — HomeCare is "PERS 2.0" |
| Remote Patient Monitoring | $14.2B | 12.8% | RPM codes enable subscription revenue |
| Aging-in-Place Technology | $9.1B | 15.1% | HomeCare's core value proposition |
Combined SAM: ~$25B (US), growing at ~12% CAGR
| Target | Population | Penetration | Revenue Potential |
|---|---|---|---|
| US seniors living alone, 75+ | ~7M households | 0.1% (7,000 units) | ~$2.8M hardware + $2.4M ARR |
| B2B: US home care agencies | ~33,000 agencies | 0.5% (165 agencies x 20 units) | ~$1.3M hardware + $1.2M ARR |
| Year 3 combined | — | — | ~$4.1M hardware + $3.6M ARR |
| Code | Description | Reimbursement | Impact |
|---|---|---|---|
CPT 99453 | RPM device setup | $19.32 | One-time per patient |
CPT 99454 | RPM device supply (monthly) | $55.92/mo | Recurring — covers device cost |
CPT 99457 | RPM treatment management (first 20 min) | $50.94/mo | Recurring — clinical oversight |
CPT 99458 | RPM additional 20 min | $41.17/mo | Additional revenue |
Monthly reimbursement per patient: up to $148/mo — far exceeding HomeCare's €29/mo subscription price.
Investor takeaway: CMS reimbursement alone could cover HomeCare's entire subscription cost and then some. This creates a path to $0 out-of-pocket for the consumer — the ultimate adoption accelerator.
| Factor | Value |
|---|---|
| Problem cost | $88B+ / year (conservative; likely $120B+ with updated data) |
| Prevention spending | ~$2B / year |
| Gap ratio | 44:1 (or 60:1 with updated figures) |
| Population growth | +28% by 2035 |
| Current solutions | Fundamentally broken (80% pendant non-activation) |
| Regulatory tailwind | CMS RPM codes enable $148/mo reimbursement |
| Big Tech | Retreated (Amazon, Google, Best Buy all exited 2024-2025) |
The PERS market ($2B) is mature and growing slowly (5-6%). But it's being absorbed into the larger aging-in-place technology market ($9.1B, 15% CAGR) and remote patient monitoring market ($14.2B, 12.8% CAGR). The convergence creates a $25B+ opportunity.
| Metric | Value | Source Year |
|---|---|---|
| Annual cost of preventable home emergencies | $88B+ | 2023 composite |
| Current prevention technology spending | ~$2B | 2024 |
| Prevention-to-treatment spending ratio | 1:40 | Derived |
| US population 65+ (2024) | 61.2M | Census 2024 |
| US population 65+ (2030) | 71.6M (+17%) | Census projection |
| US population 65+ (2035) | 78.0M (+28%) | Census projection |
| Seniors living alone | 16.2M | ACL 2023 |
| Without any alert system | ~90% | Survey 2023 |
| Pendant non-activation during falls | 80% | BMJ 2008 / JMIR 2021 |
| Want to age in place | 75% | AARP 2024 |
| RPM reimbursement potential | $148/mo per patient | CMS 2024 |
| Combined SAM | ~$25B (US) | 2024 composite |
| SAM CAGR | ~12% | Weighted average |
| Aging-in-place tech CAGR | 15.1% | Market research 2024 |
| 85+ segment growth | ~5%/yr | Census projection |
Sources: CDC, CMS, US Census Bureau, NFPA, AARP, ACL, BMJ, JMIR Aging, BMC Geriatrics, Grand View Research, MarketsandMarkets, Market Data Forecast, S&P Global, Straits Research, Data M Intelligence, TheSeniorList.